Blueprint
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of
Report (date of earliest event reported): April 15,
2019
CEL-SCI CORPORATION
(Exact
name of Registrant as specified in its charter)
Colorado
|
01-11889
|
84-0916344
|
(State or other
jurisdiction of
incorporation)
|
(Commission File
No.)
|
(IRS
Employer Identification
No.)
|
8229
Boone Boulevard, Suite 802
Vienna, Virginia 22182
(Address
of principal executive offices, including Zip Code)
Registrant’s telephone number, including area code:
(703) 506-9460
N/A
(Former
name or former address if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant
under any of the following provisions:
☐ Written
communications pursuant to Rule 425 under the Securities Act (17CFR
230.425)
|
☐ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
☐ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)
|
☐ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-14c))
|
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (§203.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§204.12b-2 of this chapter.
Emerging
growth company ⬜
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
⬜
Item
8.01
Other Events.
Since
January 1, 2019 through April 15, 2019, CEL-SCI Corporation has
received approximately $8.9 million through the exercise of
warrants to purchase shares of the Company's common stock. As of
April 15, 2019, CEL-SCI had 33,033,395 outstanding shares of common
stock.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
CEL-SCI CORPORATION
|
|
|
|
|
|
Date: April 15,
2019
|
By:
|
/s/ Geert
Kersten
|
|
|
|
Geert
Kersten
|
|
|
|
Chief Executive
Officer
|
|
Cel-Sci
8-K Item 8.01 Warrant Exercises 4-15-19